Lipocine, a specialty pharmaceutical company, announced completion of a definitive phlebotomy study (Phlebotomy Study) to assess the extent, if any, of clinically meaningful ex vivo conversion of ...

June 9, 2010 — The National Heart, Lung and Blood Institute (NHLBI) announced it has stopped a clinical trial in children with sickle cell disease and iron overload because the newer treatment being ...

A new drug application (NDA) has been submitted to the FDA seeking approval of rusfertide, an investigational hepcidin mimetic, for the treatment of adult patients with polycythemia vera (PV). 1 ...

There are several unanswered questions in this area. First, it is not clear how to best measure iron overload in these patients. Second, the exact mechanism whereby iron overload causes increased ...

Blood loss from phlebotomy is associated with hospital-acquired anemia, according to an article published in Archives of Internal Medicine. The researchers studied 17,676 patients with acute ...

NEWARK, Calif. & OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Protagonist Therapeutics, Inc. (PTGX) (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE ...